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We report a case of a rapidly progressing giant retroperitoneal liposarcoma weighing 22kg in a 41-year-old Japanese man,
successfully treated with surgical excision. To our knowledge, this is the largest liposarcoma in the Japanese population reported
in the literature.
1.Introduction
Liposarcoma is a common soft tissue sarcoma which occurs
in adults [1, 2]. Its common sites of occurrence are
the extremities, retroperitoneum, and inguinal region [3].
Although liposarcomas can often grow into large tumors,
resected tumors weighing over 20kg are extremely rare and
considered to be “giant liposarcomas.” Here, we report our
experience of a giant retroperitoneal liposarcoma, presum-
ably the largest reported from Japan; it weighed 22kg and
caused abdominal swelling, marked leg edema, and cough
due to the pressure it exerted on the patient’s diaphragm.
2. Case Presentation
A 41-year-old Japanese man became aware of abdominal
swelling in December 2008 but did not seek a medical
opinion until he developed marked leg edema, a 30kg
weight gain, and cough. He was hospitalized the same day
after a retroperitoneal tumor was detected by computed
tomography (CT). After hospitalization, the patient was
diagnosed with a liposarcoma by CT-guided needle biopsy.
Thepatientwasemergentlytransferredtoourhospitaldueto
worsening respiratory status. On admission his body surface
area was 2.18m2.AC Ts c a nd e t e c t e da4 3× 37 × 31cm
tumor in the right retroperitoneum, with the right kidney
signiﬁcantly displaced to the left and anterior side (Figure 1).
Whole-body CT scan detected no metastasis. His condition
was diagnosed as respiratory failure due to elevation of the
diaphragm as a consequence of the rapid growth of the
tumor (Figure 2).
We concluded that surgical resection was the only
option for saving the patient’s life, so we performed a
tumorectomy 3 weeks later through a midline incision. The
operation took 3 hours and 20 minutes, and the estimated
blood loss was 3990mL requiring 800mL blood transfusion.
During surgery, the tumor and right kidney were completely
resected.
Pathological examination showed that the resected
mass weighed 22kg and was 45 × 40 × 30cm in size
(Figure 3). Grossly, the tumor was well encapsulated and
transverse sectioning revealed a solid multinodular tumor
mass. Histopathologic analysis demonstrated many spindle
cells with high-grade atypia; some of which were lipoblasts
on a myxoid background; there were no split signals on
FISH analysis using CHOP DNA probes, thus leading to
the diagnosis of dediﬀerentiated liposarcoma (Figure 4).
Microscopically, no tumor cells were identiﬁed in the right
kidney and this was an R0 resection. He declined adjuvant
therapy. The patient was discharged from our hospital after2 Advances in Urology
Figure 1: Computerized tomography detected a 43 × 37 × 31-
cm tumor in the right retroperitoneum, and the right kidney was
deﬂected greatly to the left ventral side (white arrow).
Figure 2: Chest X-ray showed that elevation of the diaphragm due
to rapid growth of retroperitoneal tumor and cardiac enlargement.
18 days. His body surface area at discharge was 1.66m2.
A CT scan performed 12 months after surgery detected no
recurrence.
3. Discussion
Liposarcoma is the most common soft tissue sarcoma and
accounts for 10–20% of all cases. It commonly occurs
between 40–60 years of age and has a 1:1 ratio between
genders [1, 2]. Liposarcoma occurs most commonly in the
extremities (52%), retroperitoneum (19%), and inguinal
region (12%) [3]. Although liposarcomas sometimes weigh
as much as 10kg or more, those exceeding 20kg are
extremely rare. Some published reports have noted tumors
weighing 103.6lb (46.6kg) [4], 42kg [5], and 18kg [6].
According to previous reports, the heaviest tumor to date in
Figure 3: Intra-operative ﬁndings. The retroperitoneal tumor
weighing 22kg was extirpated.
the Japanese population was 18kg [7]. Thus, we believe that
we have resected the largest retroperitoneal liposarcoma in
Japan.
According to the WHO classiﬁcation, liposarcomas can
be classiﬁed into ﬁve histologic types: well diﬀerentiated,
myxoid, round cell, pleomorphic, and dediﬀerentiated [8].
The myxoid and round-cell types are considered subtypes
because of their common chromosomal translocation [9–
12].
Dalalargued,onthebasisofastudyconductedatasingle
facility, that the most common forms of liposarcoma are well
diﬀerentiated (46%), dediﬀerentiated (18%), myxoid (18%),
r o u n dc e l l( 1 0 % ) ,a n dp l e o m o r p h i c( 8 % ) .
A chimera gene, TLS-CHOP, which is only found in
myxoid-type sarcomas, was discovered in a myxoid-type
liposarcoma. This gene is presumed to be responsible for
tumor growth [9–12]. It can often be diﬃcult to distinguish
between myxoid-type and dediﬀerentiated liposarcomas.
Nevertheless, we observed no split signals on FISH analysis
using CHOP DNA probes.
Surgical resection is still the principal treatment, and
combined resection of involved organs is necessary for an
R0 resection in many cases. A previous report stated that
combined resection of adjacent organs is required in 75% of
retroperitoneal tumors treated by tumorectomy [13].
Multimodality therapies such as chemotherapy with
ifosfamide, anthracycline, and doxorubicin, as well as
the combination of intraoperative and intensity-modulated
radiotherapy, are also eﬀective [14]. Recently, Ecteinascidin
(ET743), an alkaloid derived from the Caribbean sea squirt
(Ecteinascidia turbinate), has shown deﬁnite activity in soft
tissue sarcoma in clinical trials [14]. However, high-grade
liposarcoma may beneﬁt from radiotherapy or chemother-
apy with a reduction in local recurrence, but with no beneﬁt
in overall survival [14]. Histologic grading is important in
liposarcoma, with disease-speciﬁc survival rates after 5 years
of 93% for well-diﬀerentiated, 74–92% for myxoid/round-
cell, 59% for pleomorphic, and 44% for dediﬀerentiated
forms [15]. 83% of patients with dediﬀerentiated liposar-
comas develop local recurrence, and 30% develop distantAdvances in Urology 3
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Figure 4: Histopathological ﬁndings of the tumor diagnosed ded-
iﬀerentiated liposarcoma (HE stain, original magniﬁcation x200).
(a) Most of the tumor cells consisted of spindle cells with high-
grade atypia. (b) Some of which were identiﬁed to be lipoblasts in a
myxoid background.
metastasis [16]. Here, we report the largest retroperitoneal
liposarcoma in Japan. Judging from evidence in previously
published reports, we expect a poor prognosis for the patient
and will be closely following him for recurrence.
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